Vivani Medical, Inc. (VANI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q4 '15: 2.3M Q1 '16: 1.1K Q1 '17: 1M Q2 '17: 2.2M Q3 '17: 1.6M Q4 '17: 3.1M Q1 '18: 976K Q2 '18: 1.9M Q3 '18: 2.2M Q4 '18: 1.8M Q1 '19: 1.1M Q2 '19: 1.3M Q3 '19: 472K Q4 '19: 497K Q2 '20: 0 Q2 '21: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q1 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19 Q3 '24 Q2 '25

Gross Profit Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q1 '16: 141K Q2 '16: -2.2M Q3 '16: -1.4M Q4 '16: -2.6M Q1 '17: -118K Q2 '17: 1.1M Q3 '17: 609K Q4 '17: 1.2M Q1 '18: 308K Q2 '18: 1.1M Q3 '18: 462K Q4 '18: 167K Q1 '19: 397K Q2 '19: 349K Q3 '19: 108K Q4 '19: 373K Q2 '20: 0 Q4 '20: 500K Q2 '21: 0 Q4 '21: 130K Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q2 '20 Q4 '21

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -3.5M Q4 '21: -1.3M Q1 '22: -3.9M Q2 '22: -4.1M Q3 '22: -5.4M Q4 '22: -7.8M Q1 '23: -6.6M Q2 '23: -7M Q3 '23: -7.1M Q4 '23: -6.2M Q1 '24: -6.2M Q2 '24: -5.7M Q3 '24: -6.3M Q4 '24: -6.5M Q1 '25: -6.6M Q2 '25: -7.5M Q3 '25: -6.7M Q4 '25: -6.8M Q1 '26: -6.8M Q2 '26: -6.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -3.5M Q4 '21: -1.3M Q1 '22: -3.9M Q2 '22: -4.1M Q3 '22: 1.4M Q4 '22: -7.3M Q1 '23: -6.3M Q2 '23: -6.5M Q3 '23: -6.8M Q4 '23: -6M Q1 '24: -6M Q2 '24: -5.4M Q3 '24: -6M Q4 '24: -6M Q1 '25: -6.3M Q2 '25: -7.1M Q3 '25: -6.5M Q4 '25: -6.6M Q1 '26: -6.8M Q2 '26: -6.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q4 '14: 1.4M Q1 '15: 1.3K Q2 '15: 1.6M Q3 '15: 757.1K Q4 '15: 1.7M Q1 '16: 912 Q1 '17: 1.1M Q2 '17: 1.1M Q3 '17: 1M Q4 '17: 1.9M Q1 '18: 668K Q2 '18: 836K Q3 '18: 1.8M Q4 '18: 1.6M Q1 '19: 731K Q2 '19: 933K Q3 '19: 364K Q4 '19: 124K Q2 '20: 0 Q2 '21: 0 Q1 '15 Q4 '15 Q2 '17 Q1 '18 Q4 '18 Q3 '19 Q2 '21

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -3M Q4 '21: -3M Q1 '22: -3.2M Q2 '22: -3.4M Q3 '22: -7M Q4 '22: -5.2M Q1 '23: -7M Q2 '23: -5.5M Q3 '23: -7.7M Q4 '23: -3.5M Q1 '24: -4.5M Q2 '24: -4.8M Q3 '24: -5.7M Q4 '24: -5.8M Q1 '25: -5.2M Q2 '25: -6.1M Q3 '25: -6.4M Q4 '25: -6.7M Q1 '26: -6.2M Q2 '26: -6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q4 '20: -1.5M Q4 '21: -3.2M Q1 '22: -3.2M Q2 '22: -3.5M Q3 '22: -7.1M Q4 '22: -5.3M Q1 '23: -7M Q2 '23: -5.6M Q3 '23: -7.8M Q4 '23: -4.2M Q1 '24: -4.7M Q2 '24: -4.8M Q3 '24: -5.7M Q4 '24: -6.1M Q1 '25: -5.2M Q2 '25: -6.2M Q3 '25: -7.2M Q4 '25: -7M Q1 '26: -6.2M Q2 '26: -6.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q3 '21: 33.8K Q1 '22: 36.8K Q2 '22: 36.9K Q3 '22: 38.5K Q1 '23: 50.8K Q2 '23: 50.8M Q3 '23: 50.8M Q1 '24: 52.2M Q2 '24: 55M Q3 '24: 55.2M Q1 '25: 59.2M Q2 '25: 59.2M Q3 '25: 59.7M Q1 '26: 81.3M Q2 '26: 87.1M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q1 '19: -2.00 Q2 '19: -2.44 Q3 '19: -2.81 Q4 '19: -2.35 Q1 '20: -2.12 Q2 '20: -1.71 Q3 '20: -1.29 Q4 '20: -0.85 Q1 '21: -0.40 Q2 '21: -0.33 Q1 '24: -0.49 Q2 '24: -0.46 Q3 '24: -0.44 Q4 '24: -0.44 Q1 '25: -0.43 Q2 '25: -0.45 Q3 '25: -0.45 Q4 '25: -0.43 Q1 '26: -0.40 Q2 '26: -0.35 Q2 '19 Q1 '20 Q4 '20 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.